Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Current Deferred Revenue: 2022-2024

Historic Current Deferred Revenue for Crinetics Pharmaceuticals (CRNX) over the last 3 years, with Dec 2024 value amounting to $2.2 million.

  • Crinetics Pharmaceuticals' Current Deferred Revenue fell 2.55% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 2.55%. This contributed to the annual value of $2.2 million for FY2024, which is 5.84% up from last year.
  • Crinetics Pharmaceuticals' Current Deferred Revenue amounted to $2.2 million in FY2024, which was up 5.84% from $2.1 million recorded in FY2023.
  • In the past 5 years, Crinetics Pharmaceuticals' Current Deferred Revenue registered a high of $8.3 million during FY2022, and its lowest value of $2.1 million during FY2023.
  • For the 3-year period, Crinetics Pharmaceuticals' Current Deferred Revenue averaged around $4.2 million, with its median value being $2.2 million (2024).
  • In the last 5 years, Crinetics Pharmaceuticals' Current Deferred Revenue tumbled by 75.35% in 2023 and then grew by 5.84% in 2024.
  • Yearly analysis of 3 years shows Crinetics Pharmaceuticals' Current Deferred Revenue stood at $8.3 million in 2022, then slumped by 75.35% to $2.1 million in 2023, then increased by 5.84% to $2.2 million in 2024.